CN103028041B - 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 - Google Patents
用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103028041B CN103028041B CN201210594240.XA CN201210594240A CN103028041B CN 103028041 B CN103028041 B CN 103028041B CN 201210594240 A CN201210594240 A CN 201210594240A CN 103028041 B CN103028041 B CN 103028041B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight portions
- filtrate
- radix
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 192
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- 238000002360 preparation method Methods 0.000 title claims description 21
- 230000001154 acute effect Effects 0.000 title abstract description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 32
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 32
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 244000080767 Areca catechu Species 0.000 claims abstract description 30
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 12
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 187
- 239000000706 filtrate Substances 0.000 claims description 180
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 107
- 239000000843 powder Substances 0.000 claims description 101
- 239000012153 distilled water Substances 0.000 claims description 83
- 239000000341 volatile oil Substances 0.000 claims description 60
- 229940079593 drug Drugs 0.000 claims description 59
- 238000001914 filtration Methods 0.000 claims description 47
- 241000628997 Flos Species 0.000 claims description 46
- 239000009670 cang er zi wan Substances 0.000 claims description 40
- 206010001076 Acute sinusitis Diseases 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 37
- 238000003756 stirring Methods 0.000 claims description 33
- 239000000284 extract Substances 0.000 claims description 32
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 239000007923 nasal drop Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 20
- 239000007921 spray Substances 0.000 claims description 19
- 235000019640 taste Nutrition 0.000 claims description 19
- 239000006071 cream Substances 0.000 claims description 18
- 238000005507 spraying Methods 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 239000002552 dosage form Substances 0.000 claims description 17
- 241000563984 Ampelopsis Species 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 16
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 238000004821 distillation Methods 0.000 claims description 15
- 238000003809 water extraction Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 12
- 230000006837 decompression Effects 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 12
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 12
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 12
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 12
- -1 filter Substances 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- 230000000274 adsorptive effect Effects 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 235000008504 concentrate Nutrition 0.000 claims description 7
- 239000007922 nasal spray Substances 0.000 claims description 7
- 229940097496 nasal spray Drugs 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 238000003958 fumigation Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 65
- 230000008901 benefit Effects 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000247747 Coptis groenlandica Species 0.000 abstract 2
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 241000218378 Magnolia Species 0.000 abstract 2
- 244000067505 Xanthium strumarium Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 2
- 235000011477 liquorice Nutrition 0.000 abstract 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000123835 Ampelopsis japonica Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 244000270834 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000967218 Selaginella tamariscina Species 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000018718 Verbena officinalis Nutrition 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 55
- 210000000952 spleen Anatomy 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 31
- 239000008280 blood Substances 0.000 description 31
- 230000001737 promoting effect Effects 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 29
- 201000009890 sinusitis Diseases 0.000 description 28
- 210000000232 gallbladder Anatomy 0.000 description 25
- 241001465754 Metazoa Species 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 23
- 210000002784 stomach Anatomy 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 210000004877 mucosa Anatomy 0.000 description 17
- 210000001331 nose Anatomy 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 239000003440 toxic substance Substances 0.000 description 17
- 230000001717 pathogenic effect Effects 0.000 description 16
- 230000008961 swelling Effects 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 14
- 230000003203 everyday effect Effects 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 238000003304 gavage Methods 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000003928 nasal cavity Anatomy 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 12
- 206010039101 Rhinorrhoea Diseases 0.000 description 12
- 210000004556 brain Anatomy 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 12
- 230000028327 secretion Effects 0.000 description 12
- 241000700199 Cavia porcellus Species 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 201000004624 Dermatitis Diseases 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 10
- 238000010171 animal model Methods 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000002850 nasal mucosa Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 210000003695 paranasal sinus Anatomy 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 231100000111 LD50 Toxicity 0.000 description 6
- 206010028748 Nasal obstruction Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 206010061428 decreased appetite Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- 208000036071 Rhinorrhea Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 229940100601 interleukin-6 Drugs 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 201000004792 malaria Diseases 0.000 description 5
- 208000010753 nasal discharge Diseases 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 108010074051 C-Reactive Protein Proteins 0.000 description 4
- 102100032752 C-reactive protein Human genes 0.000 description 4
- 206010009137 Chronic sinusitis Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229960003444 immunosuppressant agent Drugs 0.000 description 4
- 230000001861 immunosuppressant effect Effects 0.000 description 4
- 239000003018 immunosuppressive agent Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000004086 maxillary sinus Anatomy 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010002653 Anosmia Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010050515 Hyposmia Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 210000004081 cilia Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 235000019559 hyposmia Nutrition 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- XRRONFCBYFZWTM-UHFFFAOYSA-N octadecanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(O)=O XRRONFCBYFZWTM-UHFFFAOYSA-N 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 244000235603 Acacia catechu Species 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000158526 Nasalis Species 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 230000002804 anti-anaphylactic effect Effects 0.000 description 2
- 230000002973 anti-dopamine Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000023513 hiccough Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027906 Monocytosis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 229960000479 ceftriaxone sodium Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- FDRNWTJTHBSPMW-GNXCPKRQSA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C([O-])=NN1C FDRNWTJTHBSPMW-GNXCPKRQSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000013129 endoscopic sinus surgery Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 201000006916 frontal sinusitis Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000020985 infant symptom Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000007436 olfactory function Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
Description
组别 | n | IL-6 | CRP |
空白组 | 10 | 36.583±2.971 | 6.251±1.685 |
模型组 | 10 | 69.117±2.008 | 27.364±2.073 |
治疗组 | 10 | 38.292±1.696 | 7.813±1.334 |
组别 | 起效时间(d) | 痊愈时间(d) |
治疗组 | 3.2±0.6 | 11.6±1.1 |
对照组 | 5.1±0.9 | 17.2±1.4 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594240.XA CN103028041B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210594240.XA CN103028041B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103028041A CN103028041A (zh) | 2013-04-10 |
CN103028041B true CN103028041B (zh) | 2014-06-18 |
Family
ID=48015770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210594240.XA Expired - Fee Related CN103028041B (zh) | 2012-12-29 | 2012-12-29 | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103028041B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103655767B (zh) * | 2013-11-25 | 2016-04-20 | 苏建忠 | 治疗鼻窦炎的内服外用组合性中药制剂 |
CN107670010A (zh) * | 2017-11-02 | 2018-02-09 | 大连大学 | 一种治疗鼻炎的喷雾剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152435A (zh) * | 2007-09-20 | 2008-04-02 | 吴月 | 治疗急性鼻窦炎的中药 |
CN101164613A (zh) * | 2007-10-12 | 2008-04-23 | 闫改转 | 一种治疗鼻炎的中成药 |
CN102240377A (zh) * | 2010-05-12 | 2011-11-16 | 陈少杰 | 一种鼻炎药的配方 |
-
2012
- 2012-12-29 CN CN201210594240.XA patent/CN103028041B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152435A (zh) * | 2007-09-20 | 2008-04-02 | 吴月 | 治疗急性鼻窦炎的中药 |
CN101164613A (zh) * | 2007-10-12 | 2008-04-23 | 闫改转 | 一种治疗鼻炎的中成药 |
CN102240377A (zh) * | 2010-05-12 | 2011-11-16 | 陈少杰 | 一种鼻炎药的配方 |
Also Published As
Publication number | Publication date |
---|---|
CN103028041A (zh) | 2013-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103156984B (zh) | 用于治疗牙龈炎的中药组合物及其制备方法 | |
CN103120760B (zh) | 用于治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN101766787B (zh) | 治疗高热、咳喘的灌肠液 | |
CN105326908A (zh) | 一种治疗鼻炎的药物组合物及其用途 | |
CN105213738A (zh) | 一种用于治疗小儿便秘的中药及其制备方法 | |
CN103028041B (zh) | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 | |
CN103191331B (zh) | 用于治疗支气管哮喘缓解期的中药组合物 | |
CN105343498A (zh) | 一种用于润肺的中药制剂及其制备方法与应用 | |
CN104940718A (zh) | 一种治疗慢性胆囊炎的药物组合物及其制备方法 | |
CN104784549A (zh) | 用于治疗变应性鼻炎的内服中药 | |
CN103028040B (zh) | 用于治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN103705639B (zh) | 一种治疗脑积水的中药制剂 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN103301373B (zh) | 一种治疗产后会阴粘膜病变的药物组合物 | |
CN105998725A (zh) | 用于治疗矽肺的中药制剂 | |
CN105412696A (zh) | 治疗肝郁脾虚证型肠易激综合征的药物 | |
CN103041172B (zh) | 用于治疗慢性鼻窦炎的中药组合物及其制备方法 | |
CN102716341B (zh) | 治疗急性消化性溃疡出血的中药组合物及其制备方法 | |
CN103705856B (zh) | 用于预防放化疗急性放射反应的中药组合物 | |
CN103041194B (zh) | 用于治疗慢性湿疹的中药组合物及其制备方法 | |
CN105213848A (zh) | 用于治疗心脾积热型复发性口腔溃疡的药物 | |
CN105288054A (zh) | 治疗脾肾阳虚证型肠易激综合征的药物 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 | |
CN105535626A (zh) | 用于联合抗涝药治疗肺结核的中药药物 | |
CN105214047A (zh) | 用于治疗肾阳亏虚型过敏性鼻炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Chonghui Inventor after: Jiang Feng Inventor after: Wu Aifeng Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: WANG CHONGHUI JIANG FENG WU AIFENG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Patentee before: Qingdao Hengbo Instrument Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180328 Address after: 401120 Chongqing Yubei District Hui Xing Street Xingke Road No. 293 with mountain name 7 9 Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140618 Termination date: 20181229 |